Economic Evaluation and Catheter-related Bloodstream Infections
Open Access
- 1 June 2007
- journal article
- review article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (6) , 815-823
- https://doi.org/10.3201/eid1306.070048
Abstract
Catheter-related bloodstream infections are a serious problem. Many interventions reduce risk, and some have been evaluated in cost-effectiveness studies. We review the usefulness and quality of these economic studies. Evidence is incomplete, and data required to inform a coherent policy are missing. The cost-effectiveness studies are characterized by a lack of transparency, short time-horizons, and narrow economic perspectives. Data quality is low for some important model parameters. Authors of future economic evaluations should aim to model the complete policy and not just single interventions. They should be rigorous in developing the structure of the economic model, include all relevant economic outcomes, use a systematic approach for selecting data sources for model parameters, and propagate the effect of uncertainty in model parameters on conclusions. This will inform future data collection and improve our understanding of the economics of preventing these infections.Keywords
This publication has 40 references indexed in Scilit:
- When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature*Critical Care Medicine, 2006
- Whither trial‐based economic evaluation for health care decision making?Health Economics, 2006
- Are Antimicrobial-Impregnated Catheters Effective? Replace the Water and Grab Your Washcloth, Because We Have a Baby to WashClinical Infectious Diseases, 2004
- National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004American Journal of Infection Control, 2004
- Use of Maximal Sterile Barriers during Central Venous Catheter Insertion: Clinical and Economic OutcomesClinical Infectious Diseases, 2004
- Vascular Catheter Site Care: The Clinical and Economic Benefits of Chlorhexidine Gluconate Compared with Povidone IodineClinical Infectious Diseases, 2003
- Assessing Quality in Decision Analytic Cost-Effectiveness ModelsPharmacoEconomics, 2000
- Infection Risk and Cost-Effectiveness of Commercial Bags or Glass Bottles for Total Parenteral NutritionInfection Control & Hospital Epidemiology, 1997
- Economic evaluations in the critical care literatureCritical Care Medicine, 1996
- Optimal Interval for Triple-lumen Catheter ChangesMedical Decision Making, 1995